SC 13G

Company

Corvus Pharmaceuticals, Inc.

Filed

April 8, 2016

Accession Number

0001104659-16-110585

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →